Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 18 May 2022
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.874696

Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990

www.frontiersin.orgBin Chen1† www.frontiersin.orgLinguangjin Wu1† www.frontiersin.orgXiaoxia Tang1† www.frontiersin.orgTing Wang1 www.frontiersin.orgShuyun Wang1 www.frontiersin.orgHongjie Yu1 www.frontiersin.orgGuangsheng Wan1 www.frontiersin.orgManli Xie1 www.frontiersin.orgRuijuan Zhang2*‡ www.frontiersin.orgHaijuan Xiao3*‡ www.frontiersin.orgWanli Deng1*‡
  • 1Department of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • 2Department of Traditional Chinese Medicine, Putuo People’s Hospital, Tongji University, Shanghai, China
  • 3Department of Oncology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China
This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Chen B, Wu L, Tang X, Wang T, Wang S, Yu H, Wan G, Xie M, Zhang R, Xiao H and Deng W (2022) Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990. Front. Pharmacol. 13:874696. doi: 10.3389/fphar.2022.874696

Received: 12 February 2022; Accepted: 07 April 2022;
Published: 18 May 2022; Retracted: 6 July 2023.

Edited by:

Hailian Shi, Shanghai University of Traditional Chinese Medicine, China

Reviewed by:

Liqun Jia, China-Japan Friendship Hospital, China
Li Feng, National Cancer Center of China, China
Download